X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (155) 155
gastroenterology & hepatology (119) 119
female (115) 115
male (112) 112
adult (110) 110
middle aged (86) 86
gastroenterology and hepatology (84) 84
crohn's disease (55) 55
aged (52) 52
surgery (48) 48
treatment outcome (45) 45
infliximab (42) 42
adolescent (41) 41
inflammatory-bowel-disease (41) 41
life sciences (40) 40
inflammatory bowel disease (33) 33
young adult (33) 33
ulcerative colitis (29) 29
diagnosis (28) 28
prospective studies (28) 28
retrospective studies (28) 28
abridged index medicus (27) 27
crohns-disease (26) 26
therapy (25) 25
crohn disease - drug therapy (24) 24
recurrence (23) 23
care and treatment (22) 22
follow-up studies (22) 22
ulcerative-colitis (22) 22
immunosuppressive agents - therapeutic use (21) 21
risk factors (21) 21
crohn disease - complications (20) 20
management (20) 20
medical research (20) 20
severity of illness index (20) 20
time factors (20) 20
analysis (19) 19
endoscopy (19) 19
inflammatory bowel diseases (19) 19
aged, 80 and over (18) 18
intestine (18) 18
medicine, experimental (18) 18
organic chemistry (17) 17
[chim.orga]chemical sciences/organic chemistry (16) 16
chemical sciences (16) 16
human health and pathology (16) 16
microbiology (16) 16
patients (16) 16
azathioprine (15) 15
colon (15) 15
consensus (15) 15
human necessities (15) 15
pharmacology & pharmacy (15) 15
beer (14) 14
biochemistry (14) 14
chemistry (14) 14
crohn disease - diagnosis (14) 14
crohn disease - surgery (14) 14
enzymology (14) 14
metallurgy (14) 14
mutation or genetic engineering (14) 14
spirits (14) 14
tumor necrosis factor (14) 14
vinegar (14) 14
wine (14) 14
colitis (13) 13
gastrointestinal agents - therapeutic use (13) 13
hygiene (13) 13
hépatology and gastroenterology (13) 13
inflammatory bowel diseases - complications (13) 13
maintenance therapy (13) 13
medical or veterinary science (13) 13
remission (13) 13
cancer (12) 12
case-control studies (12) 12
crohns disease (12) 12
gastrointestinal diseases (12) 12
ibd (12) 12
multivariate analysis (12) 12
prognosis (12) 12
tumor necrosis factor-alpha - antagonists & inhibitors (12) 12
[ chim.orga ] chemical sciences/organic chemistry (11) 11
antibodies, monoclonal - therapeutic use (11) 11
bifidobacterium (11) 11
biopsy (11) 11
crohn disease - therapy (11) 11
feces - microbiology (11) 11
france (11) 11
colectomy (10) 10
colitis, ulcerative - drug therapy (10) 10
compositions or test papers therefor (10) 10
condition-responsive control in microbiological orenzymological processes (10) 10
gastroenterology (10) 10
inflammatory bowel diseases - drug therapy (10) 10
measuring or testing processes involving enzymes, nucleicacids or microorganisms (10) 10
metaanalysis (10) 10
nutrition & dietetics (10) 10
processes of preparing such compositions (10) 10
remission induction (10) 10
safety (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9701, pp. 1617 - 1625
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1909 - 1915
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 199 - 199
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 10, p. e13160
Journal Article
Gut, ISSN 0017-5749, 02/2013, Volume 62, Issue 2, pp. 201 - 208
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 53 - 53
ObjectiveThe efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 10/2010, Volume 105, Issue 10, pp. 2262 - 2275
Journal Article
Journal Article
Journal Article
Molecular and cellular biology, ISSN 1098-5549, 2010, Volume 30, Issue 11, pp. 2636 - 2650
Journal Article